Steven L. Teitelbaum

Steven L. Teitelbaum's AcademicInfluence.com Rankings

Physics

#3187

World Rank

#4570

Historical Rank

#1196

USA Rank

physics Degrees

Download Badge

Physics

Steven L. Teitelbaum's Degrees

PhD Physics Stanford University

Why Is Steven L. Teitelbaum Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Steven L. Teitelbaum's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Bone resorption by osteoclasts. (2000) (3622)
Genetic regulation of osteoclast development and function (2003) (1578)
TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. (2000) (1313)
Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. (1999) (800)
Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts. (2000) (727)
IL-1 mediates TNF-induced osteoclastogenesis. (2005) (714)
Osteoclasts: what do they do and how do they do it? (2007) (644)
Osteopetrosis in mice lacking haematopoietic transcription factor PU.1 (1997) (560)
Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy (2000) (557)
Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation (2008) (552)
Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin alpha v beta 3 potentiate bone resorption. (1993) (533)
Successful bone-marrow transplantation for infantile malignant osteopetrosis. (1980) (446)
Autophagy proteins regulate the secretory component of osteoclastic bone resorption. (2011) (393)
Induction of monocytic differentiation and bone resorption by 1,25-dihydroxyvitamin D3. (1983) (383)
Mechanisms of disease osteopetrosis (2004) (377)
Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration. (1979) (374)
Tumor Necrosis Factor-α Mediates Orthopedic Implant Osteolysis (1999) (364)
Glucocorticoids suppress bone formation via the osteoclast. (2006) (358)
The osteoclast: friend or foe? (2008) (343)
Osteoclasts: New Insights (2013) (312)
Spontaneous release of interleukin 1 from human blood monocytes reflects bone formation in idiopathic osteoporosis. (1987) (311)
Vav3 regulates osteoclast function and bone mass (2005) (287)
Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor. (1997) (286)
Isolated osteoclasts resorb the organic and inorganic components of bone (1986) (286)
A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo. (1997) (284)
αvβ3 and macrophage colony‐stimulating factor: partners in osteoclast biology (2005) (276)
M-CSF mediates TNF-induced inflammatory osteolysis. (2005) (268)
SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts (2002) (265)
Recruitment of osteoclast precursors by purified bone matrix constituents (1982) (261)
The IκB Function of NF-κB2 p100 Controls Stimulated Osteoclastogenesis (2003) (258)
Syk, c-Src, the αvβ3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption (2007) (255)
Contact-mediated bone resorption by human monocytes in vitro. (1978) (247)
NOTCH1 Regulates Osteoclastogenesis Directly in Osteoclast Precursors and Indirectly via Osteoblast Lineage Cells* (2008) (214)
Correction of abnormal bone and mineral metabolism in chronic streptozotocin-induced diabetes mellitus in the rat by insulin therapy. (1981) (208)
Interleukin-4 Reversibly Inhibits Osteoclastogenesis via Inhibition of NF-κB and Mitogen-activated Protein Kinase Signaling* (2002) (206)
Human alveolar macrophages produce a fibroblast-like collagenase and collagenase inhibitor. (1985) (205)
Tumor necrosis factor receptors types 1 and 2 differentially regulate osteoclastogenesis. (2000) (203)
Crystal structure of the TRANCE/RANKL cytokine reveals determinants of receptor-ligand specificity. (2001) (194)
Dynamic changes in the osteoclast cytoskeleton in response to growth factors and cell attachment are controlled by β3 integrin (2003) (189)
Relapsing polychondritis. Analytical literature review and studies on pathogenesis. (1966) (185)
Marrow Stromal Cells and Osteoclast Precursors Differentially Contribute to TNF-α-Induced Osteoclastogenesis In Vivo1 (2004) (182)
Characterization of the Osteoclast Ruffled Border Chloride Channel and Its Role in Bone Resorption* (1997) (181)
Tumor necrosis factor-alpha mediates orthopedic implant osteolysis. (1999) (178)
c-Fms and the αvβ3 integrin collaborate during osteoclast differentiation (2003) (177)
Mice deficient in Abl are osteoporotic and have defects in osteoblast maturation (2000) (168)
Skeletal Complications of Gaucher Disease (1985) (162)
Postmenopausal osteoporosis. A heterogeneous disorder as assessed by histomorphometric analysis of Iliac crest bone from untreated patients. (1982) (161)
The effect of streptozotocin-induced chronic diabetes mellitus on bone and mineral homeostasis in the rat. (1981) (156)
alphavbeta3 and macrophage colony-stimulating factor: partners in osteoclast biology. (2005) (154)
Osteoporosis induced in mice by overproduction of interleukin 4. (1993) (154)
Inflammatory osteolysis: a conspiracy against bone. (2017) (153)
The osteoclast and its unique cytoskeleton (2011) (152)
Effect of oral 1,25-dihydroxyvitamin D and calcium on glucocorticoid-induced osteopenia in patients with rheumatic diseases. (1984) (148)
Adult Hypophosphatasia: CLINICAL, LABORATORY, AND GENETIC INVESTIGATION OF A LARGE KINDRED WITH REVIEW OF THE LITERATURE (1979) (144)
X‐Linked Hypophosphatemia: A Clinical, Biochemical, and Histopathologic Assessment of Morbidity in Adults (1989) (141)
Osteoclasts; culprits in inflammatory osteolysis (2005) (139)
Tumor Necrosis Factor-α Activation of Nuclear Transcription Factor-κB in Marrow Macrophages Is Mediated by c-Src Tyrosine Phosphorylation of IκBα* (1998) (138)
Effects of hypervitaminosis A on the bone and mineral metabolism of the rat. (1988) (136)
TREM2 and β-Catenin Regulate Bone Homeostasis by Controlling the Rate of Osteoclastogenesis (2012) (135)
A Glanzmann’s mutation in β3 integrin specifically impairs osteoclast function (2001) (130)
Cloning of the promoter for the avian integrin beta 3 subunit gene and its regulation by 1,25-dihydroxyvitamin D3. (1993) (130)
Soluble RANKL and risk of nontraumatic fracture. (2004) (127)
Bone Turnover in Bone Biopsies of Patients with Low-Energy Cortical Fractures Receiving Bisphosphonates: A Case Series (2009) (124)
The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signaling. (2004) (124)
DAP12 couples c-Fms activation to the osteoclast cytoskeleton by recruitment of Syk. (2008) (123)
Differential action of the bisphosphonates (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) and disodium dichloromethylidene bisphosphonate (Cl2MDP) on rat macrophage-mediated bone resorption in vitro. (1982) (121)
Osteoclasts, macrophages, and the molecular mechanisms of bone resorption (1997) (119)
Osteoclasts and Arthritis (2009) (116)
Synaptotagmin VII regulates bone remodeling by modulating osteoclast and osteoblast secretion. (2008) (115)
Evidence for skeletal resistance to parathyroid hormone in magnesium deficiency. Studies in isolated perfused bone. (1979) (115)
Mouse Genome-Wide Association and Systems Genetics Identify Asxl2 As a Regulator of Bone Mineral Density and Osteoclastogenesis (2011) (114)
RANKL employs distinct binding modes to engage RANK and the osteoprotegerin decoy receptor. (2012) (111)
c-Fms and the alphavbeta3 integrin collaborate during osteoclast differentiation. (2003) (110)
Cdc42 regulates bone modeling and remodeling in mice by modulating RANKL/M-CSF signaling and osteoclast polarization. (2010) (109)
Stereospecific inhibition of alkaline phosphatase by L-tetramisole prevents in vitro cartilage calcification. (1980) (108)
Osteoclasts, integrins, and osteoporosis (2000) (107)
Inflammatory carcinoma of the breast. A Pathologic Definition (1974) (103)
Osteopetrosis, renal tubular acidosis and basal ganglia calcification in three sisters. (1980) (101)
Substrate Recognition by Osteoclast Precursors Induces C-src/Microtubule Association (1997) (100)
IL‐17 mediates estrogen‐deficient osteoporosis in an Act1‐dependent manner (2012) (100)
Transforming Growth Factor-β Up-regulates the β5Integrin Subunit Expression via Sp1 and Smad Signaling* (2000) (99)
Hypophosphatasia: Clinicopathologic Comparison of the Infantile, Childhood, and Adult Forms (1984) (98)
Direct Inhibition of NF-κB Blocks Bone Erosion Associated with Inflammatory Arthritis1 (2003) (97)
Syk, c-Src, the alphavbeta3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption. (2007) (97)
Rab3D Regulates a Novel Vesicular Trafficking Pathway That Is Required for Osteoclastic Bone Resorption (2005) (96)
Interaction of diphenylhydantoin (phenytoin) and phenobarbital with hormonal mediation of fetal rat bone resorption in vitro. (1978) (96)
High dose M‐CSF partially rescues the Dap12−/− osteoclast phenotype (2003) (96)
Exogenous hyperthyroidism with osteoporosis. (1983) (96)
Systemic mastocytosis associated with generalized osteopenia. Histopathological characterization of the skeletal lesion using undecalcified bone from two patients. (1981) (96)
Sclerosteosis: Nemogenetic and pathophysiologic analysis of an American kinship (1983) (95)
Intercellular Mitochondria Transfer to Macrophages Regulates White Adipose Tissue Homeostasis and Is Impaired in Obesity. (2020) (95)
Rac deletion in osteoclasts causes severe osteopetrosis (2011) (92)
Interleukin 4 inhibits murine osteoclast formation in vitro (1991) (91)
FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner. (2005) (86)
RANKing c-Jun in osteoclast development. (2004) (86)
Renal osteodystrophy. (1995) (85)
Generation of avian cells resembling osteoclasts from mononuclear phagocytes. (1991) (82)
Effects of semistarvation on skeletal homeostasis. (1980) (82)
TAT Fusion Proteins Containing Tyrosine 42-deleted IκBα Arrest Osteoclastogenesis* (2001) (80)
Molecular mechanisms of bone resorption (1995) (80)
Talin1 and Rap1 Are Critical for Osteoclast Function (2012) (80)
Unoccupied αvβ3 Integrin Regulates Osteoclast Apoptosis by Transmitting a Positive Death Signal (2005) (78)
1 alpha,25-dihydroxyvitamin D3 up-regulates expression of the osteoclast integrin alpha v beta 3. (1993) (78)
X-linked hypophosphatemia: skeletal mass in adults assessed by histomorphometry, computed tomography, and absorptiometry. (1991) (78)
Integrins, growth factors, and the osteoclast cytoskeleton (2010) (76)
The predictability of the histological features of uremic bone disease by non-invasive techniques (1978) (74)
Twenty years' experience with intrinsic tumors of the bony thorax at a large institution. (1972) (73)
Abnormalities of circulating 25-OH vitamin D after jejunal-lleal bypass for obesity: evidence of an adaptive response. (1977) (73)
Receptor Activator of Nuclear Factor-κB Ligand Activates Nuclear Factor-κB in Osteoclast Precursors. (2001) (71)
Significant developmental elevation in serum parathyroid hormone levels in a large kindred with familial benign (hypocalciuric) hypercalcemia. (1992) (70)
Calcium homeostasis in chronic streptozotocin-induced diabetes mellitus in the rat. (1982) (69)
Regulation of αVβ3 and αVβ5 integrins by dexamethasone in normal human osteoblastic cells (2000) (68)
Multinucleation enhances macrophage-mediated bone resorption. (1983) (67)
Postmenopausal osteoporosis, T cells, and immune dysfunction. (2004) (65)
Atheromatous embolization; a factor in peripheral gangrene. (1959) (64)
Histological studies of bone from normocalcemic post-menopausal osteoporotic patients with increased circulating parathyroid hormone. (1976) (63)
Histological analysis of undecalcified thin sections of archeological bone. (1976) (62)
Glucocorticoids and the Osteoclast (2007) (62)
Noninvasive imaging of osteoclasts in parathyroid hormone-induced osteolysis using a 64Cu-labeled RGD peptide. (2007) (61)
c-Fms Tyrosine 559 Is a Major Mediator of M-CSF-induced Proliferation of Primary Macrophages* (2007) (60)
Stem cells and osteoporosis therapy. (2010) (59)
Effect of alcohol ingestion on bone and mineral metabolism in rats. (1980) (59)
Calcifediol in chronic renal insufficiency. Skeletal response. (1976) (59)
Tumor necrosis factor‐α mediates polymethylmethacrylate particle‐induced NF‐κB activation in osteoclast precursor cells (2002) (59)
Mice Lacking the Integrin β5 Subunit Have Accelerated Osteoclast Maturation and Increased Activity in the Estrogen‐Deficient State (2004) (59)
Interleukin-4 Induces Expression of the Integrin αvβ3 via Transactivation of the β3 Gene (*) (1995) (58)
Parathyroid hormone inhibits collagen synthesis at both ribonucleic acid and protein levels in rat osteogenic sarcoma cells. (1989) (58)
Critical Role of β3 Integrin in Experimental Postmenopausal Osteoporosis (2005) (58)
Effect of testosterone therapy on bone formation in an osteoporotic hypogonadal male (1978) (56)
c-Src Links a RANK/αvβ3 Integrin Complex to the Osteoclast Cytoskeleton (2012) (55)
Systemic mastocytosis presenting as osteoporosis: a clinical and histomorphometric study. (1991) (55)
Tumor necrosis factor-alpha activation of nuclear transcription factor-kappaB in marrow macrophages is mediated by c-Src tyrosine phosphorylation of Ikappa Balpha. (1998) (54)
A Glanzmann's mutation in beta 3 integrin specifically impairs osteoclast function. (2001) (53)
Granulocyte macrophage-colony stimulating factor reciprocally regulates alphav-associated integrins on murine osteoclast precursors. (1998) (53)
Serum concentration of 25-hydroxyvitamin D in rickets of extremely premature infants (1979) (53)
1,25-Dihydroxyvitamin D3 transcriptionally activates the beta 3-integrin subunit gene in avian osteoclast precursors. (1994) (53)
Receptor activator of nuclear factor-kappa b ligand activates nuclear factor-kappa b in osteoclast precursors. (2001) (53)
Should bisphosphonates be used for long-term treatment of glucocorticoid-induced osteoporosis? (2011) (53)
Receptor Activator of Nuclear Factor-kB Ligand Activates Nuclear Factor-kB in Osteoclast Precursors* (2001) (53)
SHIP1 Negatively Regulates Proliferation of Osteoclast Precursors via Akt-Dependent Alterations in D-Type Cyclins and p271 (2006) (53)
Adipose tissue is a critical regulator of osteoarthritis (2020) (52)
Sp1/Sp3 and PU.1 Differentially Regulate β5Integrin Gene Expression in Macrophages and Osteoblasts* (2000) (51)
M-CSF Regulates the Cytoskeleton via Recruitment of a Multimeric Signaling Complex to c-Fms Tyr-559/697/721* (2007) (51)
Osteoporosis in young men: a syndrome of hypercalciuria and accelerated bone turnover. (1982) (51)
The LIM Protein, LIMD1, Regulates AP-1 Activation through an Interaction with TRAF6 to Influence Osteoclast Development* (2007) (51)
Unoccupied alpha(v)beta3 integrin regulates osteoclast apoptosis by transmitting a positive death signal. (2005) (51)
Antagonizing Integrin β3 Increases Immunosuppression in Cancer. (2016) (51)
The Src family kinase, Lyn, suppresses osteoclastogenesis in vitro and in vivo (2009) (50)
Mononuclear phagocytes osteoclasts and bone resorption (1981) (50)
Glucocorticoid enhancement of bone resorption by rat peritoneal macrophages in vitro. (1981) (50)
Transforming growth factor-beta up-regulates the beta 5 integrin subunit expression via Sp1 and Smad signaling. (2000) (48)
Osteoclasts and Integrins (2006) (48)
Expression and Regulation of RAB3 Proteins in Osteoclasts and Their Precursors (1999) (48)
ASXL2 Regulates Glucose, Lipid, and Skeletal Homeostasis. (2015) (47)
Juvenile paget disease: Life‐long features of a mildly affected young woman (1996) (47)
Antacid-induced osteomalacia and nephrolithiasis. (1978) (46)
Tumor Necrosis Factor Receptor-associated Factor 6 Is an Intranuclear Transcriptional Coactivator in Osteoclasts* (2008) (46)
Abnormal osteoclast morphology and bone remodeling in a murine model of a lysosomal storage disease. (2002) (46)
Thyrocalcitonin activity of particulate fractions of the thyroid gland. (1966) (45)
Collagenase production by smooth muscle: Correlation of immunoreactive with functional enzyme in the myometrium (1986) (45)
Histomorphometric changes in trabecular bone of renal failure patients treated with calcifediol (1981) (45)
Rodent peritoneal macrophages as bone resorbing cells (1979) (45)
Calpain-6, a Target Molecule of Glucocorticoids, Regulates Osteoclastic Bone Resorption via Cytoskeletal Organization and Microtubule Acetylation (2010) (44)
SLP-76 Couples Syk to the Osteoclast Cytoskeleton1 (2009) (44)
Sclerosteosis (1983) (43)
PGC1β Organizes the Osteoclast Cytoskeleton by Mitochondrial Biogenesis and Activation (2018) (43)
Absence of Dap12 and the αvβ3 integrin causes severe osteopetrosis (2015) (42)
Hypercalcemic hyperparathyroidism complicating oncogenic osteomalacia. Effect of successful tumor resection on mineral homeostasis. (1987) (42)
Reversible inhibition of osteoclastic activity by bone‐bound gallium (III) (1992) (42)
Vinculin Regulates Osteoclast Function* (2014) (41)
Doubling skeletal mass during adult life: The syndrome of diffuse osteosclerosis after intravenous drug abuse (1996) (40)
Tumour necrosis factor superfamily cytokines and the pathogenesis of inflammatory osteolysis (2002) (40)
Painful diffuse osteosclerosis after intravenous drug abuse. (1992) (40)
Maxillary Sinus Atelectasis (1992) (39)
Continuous ambulatory peritoneal dialysis and bone. (1986) (39)
Defects in osteoblast function but no changes in long-term repopulating potential of hematopoietic stem cells in a mouse chronic inflammatory arthritis model. (2009) (39)
Cloning and characterization of the murine β3 integrin gene promoter: Identification of an interleukin‐4 responsive element and regulation by STAT‐6 (2001) (38)
Tyrosines 559 and 807 in the cytoplasmic tail of the macrophage colony-stimulating factor receptor play distinct roles in osteoclast differentiation and function. (2002) (37)
3 Pathological manifestations of osteomalacia and Rickets (1980) (37)
Histopathology of Bacillary Angiomatosis of Lymph Node (1991) (36)
The pathophysiology of bone and joint disease. (1979) (36)
Tumor Necrosis Factor α Regulatesα vβ5 Integrin Expression by Osteoclast Precursors in Vitro and in Vivo1. (2000) (36)
An Insulin‐Sensitizing Thiazolidinedione, Which Minimally Activates PPARγ, Does Not Cause Bone Loss (2015) (36)
Correlating RANK Ligand/RANK Binding Kinetics With Osteoclast Formation and Function (2015) (36)
Macrophage-colony-stimulating factor regulates expression of the integrins alpha 4 beta 1 and alpha 5 beta 1 by murine bone marrow macrophages. (1995) (35)
1,25 dihydroxyvitamin D3 and dexamethasone induce the cyclooxygenase 1 gene in osteoclast‐supporting stromal cells (1999) (35)
The carcinoid. A collective review. (1972) (35)
Absence of metabolic bone disease in adult patients with the nephrotic syndrome and normal renal function. (1983) (35)
Ablation of Fat Cells in Adult Mice Induces Massive Bone Gain. (2020) (34)
Stercoral ulceration and perforation of the sclerodermatous colon: Report of two cases and review of the literature (1974) (33)
Competition for a Unique Response Element Mediates Retinoic Acid Inhibition of Vitamin D3-stimulated Transcription* (1996) (33)
Serotonin–norepinephrine reuptake inhibitor therapy in late-life depression is associated with increased marker of bone resorption (2013) (33)
Receptor‐mediated uptake of a mannose‐6‐phosphate bearing glycoprotein by isolated chicken osteoclasts (1988) (32)
Skeletal Abnormalities After Jejunoileal Bypass (1979) (32)
Skeletal sarcoidosis with osteopenia. (1981) (31)
Cytoskeletal dysfunction dominates in DAP12-deficient osteoclasts (2010) (31)
Tumor necrosis factor-alpha mediates polymethylmethacrylate particle-induced NF-kappaB activation in osteoclast precursor cells. (2002) (30)
Glucocorticoids modulate macrophage surface oligosaccharides and their bone binding activity. (1984) (30)
Alkaline phosphatase activity in chronic streptozotocin-induced insulin deficiency in the rat: effect of insulin replacement. (1981) (29)
Bone Calcification and Calcium Homeostasis in Rats with Non-insulin-dependent Diabetes Induced by Streptozocin (1985) (29)
Lithium inhibition of bone mineralization and osteoid formation. (1978) (29)
Osteoclast‐specific inactivation of the integrin‐linked kinase (ILK) inhibits bone resorption (2010) (29)
Adult Versus Embryonic Stem Cells: Treatments (2007) (29)
Paget Bone Disease Involving Young Adults in 3 Generations of a Korean Family (1997) (29)
Biological effects of aluminum on normal dogs: studies on the isolated perfused bone. (1987) (28)
Bone remodeling and the osteoclast (1993) (28)
Malignant osteopetrosis: a disease of abnormal osteoclast osteoclast proliferation (1981) (28)
Depression, Antidepressants, and Bone Health in Older Adults: A Systematic Review (2014) (28)
Axial osteomalacia. Clinical, laboratory and genetic investigation of an affected mother and son. (1981) (27)
Adult Stem Cell Treatments for Diseases? (2006) (27)
Estrogen enhances alpha v beta 3 integrin expression by avian osteoclast precursors via stabilization of beta 3 integrin mRNA. (1995) (26)
Parafollicular Cells in the Normal Human Thyroid (1971) (26)
Oophorectomy‐induced bone loss is attenuated in MAGP1‐deficient mice (2012) (26)
1,25‐dihydroxyvitamin D3 regulates pp60c‐src activity and expression of a pp60c‐src activating phosphatase (1997) (25)
Microfibril-associated Glycoprotein-1, an Extracellular Matrix Regulator of Bone Remodeling* (2010) (25)
Osteoporosis and integrins. (2005) (25)
Cloning of the murine beta5 integrin subunit promoter. Identification of a novel sequence mediating granulocyte-macrophage colony-stimulating factor-dependent repression of beta5 integrin gene transcription. (1999) (25)
Congenital lipodystrophy induces severe osteosclerosis (2019) (24)
PPAR-γ regulates pharmacological but not physiological or pathological osteoclast formation (2016) (24)
Retinoic acid stimulates expression of the functional osteoclast integrin αvβ3: Transcriptional activation of the β3 but not the αv gene (1996) (24)
Resection of a large chondromyxoid fibroma of the sternum: report of the first case and review of the literature. (1969) (23)
C cell follicles in the dog thyroid: Demonstration by in vivo perfusion (1970) (23)
Syk Tyrosine 317 Negatively Regulates Osteoclast Function via the Ubiquitin-Protein Isopeptide Ligase Activity of Cbl* (2009) (23)
Mast-cell proliferation in postmenopausal osteoporosis (2006) (23)
Central osteosclerosis with ectodermal dysplasia: Clinical, laboratory, radiologic, and histopathologic characterization with review of the literature (1989) (23)
The interpretation offluorescent tetracycline markers in the diagnosis of metabolic bone diseases (1982) (22)
The effects of discontinuation of aluminum exposure on aluminum-induced osteomalacia. (1986) (22)
Interleukin-4 induces expression of the integrin alpha v beta 3 via transactivation of the beta 3 gene. (1995) (22)
Defective binding of macrophages to bone in rodent osteomalacia and vitamin D deficiency. In vitro evidence for a cellular defect and altered saccharides in the bone matrix. (1983) (22)
Histomorphometric determination of formation rates of archaeological bone (1976) (22)
Fyn promotes proliferation, differentiation, survival and function of osteoclast lineage cells (2010) (22)
Fat-Produced Adipsin Regulates Inflammatory Arthritis. (2019) (21)
Significant developmental elevation in serum parathyroid hormone levels in a large kindred with familial benign (hypocalciuric) hypercalcemia (1993) (21)
Regulation of alphaVbeta3 and alphaVbeta5 integrins by dexamethasone in normal human osteoblastic cells. (2000) (20)
Tumors of the chest wall. (1969) (20)
Extraskeletal osteoclastomas responsive to dexamethasone treatment in Paget bone disease. (1997) (20)
Meningeal osteomas and chronic renal failure. (1982) (20)
Coumarin therapy in acute myocardial infarction. A Hobson's choice. (1974) (20)
Radiologic and pathologic patterns of end-plate-based vertebral sclerosis. (1988) (20)
The Integrin αvβ5 Is Expressed on Avian Osteoclast Precursors and Regulated by Retinoic Acid (1999) (19)
Effect of 24,25(OH)2D3 on PTH levels and bone histology in dogs with chronic uremia. (1984) (19)
Therapeutic implications of suppressing osteoclast formation versus function. (2016) (19)
Isolated skeletal involvement in Cushing's syndrome: response to therapy. (1981) (18)
Bone: The conundrum of glucocorticoid-induced osteoporosis (2012) (18)
1,25‐Dihydroxyvitamin D3 Induces Monocytic Differentiation of the PLB‐985 Leukemic Line and Promotes c‐fgr mRNA Expression (1991) (18)
Radiological/pathological correlations in uremic bone disease. (1977) (18)
Serum concentrations of 25-hydroxyvitamin D in rickets of extremely premature infants. (1979) (18)
Genetic variation in the serotonin transporter and HTR1B receptor predicts reduced bone formation during serotonin reuptake inhibitor treatment in older adults (2014) (17)
Novel Pure αVβ3 Integrin Antagonists That Do Not Induce Receptor Extension, Prime the Receptor, or Enhance Angiogenesis at Low Concentrations (2019) (17)
Src‐like adaptor protein regulates osteoclast generation and survival (2010) (17)
Normocalcemic hyperparathyroidism with "normal" parathyroid glands. (1971) (17)
Paxillin contracts the osteoclast cytoskeleton (2012) (17)
Cystic parathyroid gland hyperplasia--hyperparathyroidism presenting as a neck mass. (1982) (17)
ASXL1 impairs osteoclast formation by epigenetic regulation of NFATc1. (2018) (17)
Dexamethsone suppresses bone formation via the osteoclast. (2007) (16)
Enrichment of generated murine osteoclasts (1994) (16)
The relationship of monocytic cells to the differentiation and resorption of bone. (1982) (16)
Idiopathic Multicentric Osteolysis (1978) (15)
Tumor necrosis factor alpha regulates alpha(v)beta5 integrin expression by osteoclast precursors in vitro and in vivo. (2000) (15)
Spontaneous rupture of renal allotransplants. (1973) (14)
Saccharides mediate the attachment of rat macrophages to bone in vitro. (1983) (14)
Vitamin D regulates transferrin receptor expression by bone marrow macrophage precursors (1990) (14)
Altered adenosine 3',5'-monophosphate release in response to parathyroid hormone by isolated perfused bone from glucocorticoid-treated dogs. (1983) (14)
Bone collagen aggregation abnormalities in osteogenesis imperfecta (2006) (14)
1,25 dihydroxyvitamin D3 stimulates differentiation of committed murine bone marrow-derived macrophage precursor cells. (1995) (13)
Calcitonin response in circulating human lymphocytes. (1983) (13)
Twenty years' experience with soft tissue sarcomas of the chest wall at a large institution. (1972) (13)
Osteoclast Biology: Regulation of Formation and Function (2016) (13)
The effects of phosphate and vitamin D therapy on osteopenic, hypophosphatemic osteomalacia of childhood. (1976) (13)
Bone Weighs in on Obesity (2007) (12)
Hepatic lipids promote liver metastasis (2020) (12)
The relationship of biochemical and histometric determinants of uremic bone. (1979) (12)
Calcitriol for congenital osteopetrosis. (1984) (12)
FHL 2 inhibits the activated osteoclast in a TRAF 6-dependent manner (2005) (12)
The osteoclast cytoskeleton: How does it work? (2011) (12)
Manipulation of receptor oligomerization as a strategy to inhibit signaling by TNF superfamily members (2014) (11)
Idiopathic multicentric osteolysis. Report of an affected father and son. (1978) (11)
Glucocorticoids and bone resorption. (1984) (11)
Does strict phosphorus control precipitate renal osteomalacia? (1986) (11)
Pathological manifestations of osteomalacia and rickets. (1980) (11)
Halofuginone prevents estrogen‐deficient osteoporosis in mice (2012) (11)
Species differences in the immunophenotype of osteoclasts and mononuclear phagocytes (1992) (10)
Spontaneous healing of jejunoileal bypass-induced osteomalacia. (1989) (10)
Systemic mastocytosis and osteoporosis (2005) (10)
Chapter 3 – Osteoclast Biology (2001) (10)
The Osteoclast: The Pioneer of Osteoimmunology (2011) (10)
The integrin alphavbeta5 is expressed on avian osteoclast precursors and regulated by retinoic acid. (1999) (9)
Arachidonic acid metabolism by a vitamin D3‐differentiated human leukemic cell line (1988) (9)
Avian osteoblast conditioned media stimulate bone resorption by targeting multinucleating osteoclast precursors (1992) (9)
The interpretation of fluorescent tetracycline markers in the diagnosis of metabolic bone diseases. (1982) (9)
A simple procedure for the rapid histologic diagnosis of metabolic bone disease (2006) (9)
Glucocorticoids and the osteoclast. (2007) (9)
Mechanisms of tumor-induced osteolysis. (1994) (9)
Malignant osteopetrosis: a disease of abnormal osteoclast proliferation. (1981) (9)
Zap70 inhibits Syk‐mediated osteoclast function (2013) (9)
Morphologic Observations in a Case of Lethal Variant (Type I) Metatropic Dysplasia with Atypical Features: Morphology of Lethal Metatropic Dysplasia (1998) (8)
Morphological effects of vitamin D and its analogs on bone. (1976) (8)
1,25‐dihydroxyvitamin D3 and macrophage colony‐stimulating factor‐1 synergistically phosphorylate talin (1993) (8)
Osteoclast precursors circulate in avian blood (1992) (8)
Massive chondrosarcoma of the chest wall. Report of a case and concepts of management. (1970) (8)
Congenital disorders of bone and blood. (2019) (8)
Cellular and molecular mechanisms of bone resorption. (1995) (7)
Dissociation of organic acid secretion from macrophage mediated bone resorption. (1982) (7)
Renal osteodystrophy. (1984) (7)
Assessment of calcitriol and inorganic phosphate therapy before cure of oncogenous osteomalacia by resection of a mixed mesenchymal tumor. (1988) (7)
Symptomatic osteomalacia after jejunoileal bypass surgery in a patient with primary hyperparathyroidism. A study of the change in bone morphology and vitamin D metabolites before and during treatment. (1983) (7)
Myeloid-specific Asxl2 deletion limits diet-induced obesity by regulating energy expenditure. (2020) (7)
How do bone cells secrete proteins? (2010) (7)
Mixed-sclerosing-bone-dystrophy: 42-year follow-up of a case reported as osteopetrosis (1986) (6)
Regulation of epiphyseal cartilage metabolism and morphology in the chronic diabetic rat (2006) (6)
Osteoclast precursors, mononuclear phagocytes, and bone resorption. (1981) (6)
Animal Rights Pressure on Scientists (2002) (6)
Phorbol myristate acetate transactivates the avian β3 integrin gene and induces αvβ3 integrin expression (1996) (6)
Retinoic acid stimulates expression of the functional osteoclast integrin alpha v beta 3: transcriptional activation of the beta 3 but not the alpha v gene. (1996) (5)
Relationships of static and kinetic histomorphometric features of bone. (1980) (5)
Type I Phosphotidylinosotol 4-Phosphate 5-Kinase γ Regulates Osteoclasts in a Bifunctional Manner* (2013) (5)
Disassociation of lysosomal enzyme secretion and macrophage-mediated bone resorption. (1981) (5)
Novel osteoporosis mutation caused by the knock out of the hematopoietic transcription factor PU.1 in transgenic mice (1996) (5)
The Pathology of Paget’s Disease (1991) (4)
Integrins and osteoclast polarization (2010) (4)
Calcifediol (25-hydroxyvitamin D3) in the treatment of uremic bone disease. (1981) (4)
Endotoxin inhibition of macrophage-mediated bone resorption (2006) (4)
Altered metabolic rhythm of rabbit osteoblasts by tetracycline. (1981) (4)
Modulation of renal osteodystrophy by extrarenal production of calcitriol. (1995) (4)
Pseudofractures in the absence of osteomalacia (1982) (4)
Phorbol myristate acetate transactivates the avian beta 3 integrin gene and induces alpha v beta 3 integrin expression. (1996) (3)
Adult hypophosphatasia dominant inheritance in a large kindred. (1978) (3)
Teaching monograph. The pathophysiology of bone and joint disease (1979) (3)
Soluble RANKL and risk of nontraumatic fracture. Authors' reply (2004) (3)
1,25-Dihydroxycholecalciferol and macrophage differentiation with aging (1990) (3)
Calcifediol in Chronic Renal Insufficiency-Reply (1976) (3)
Comparative proteomic analysis of a cytosolic fraction from β3 integrin-deficient cells. (2012) (2)
RANKL employs distinct binding modes to engage RANK and the OPG decoy receptor (2013) (2)
Tetracycline induced phase shift in osteogenic cell populations (1977) (2)
Intestinal obstruction due to leiomyoma of the ileum. (1972) (2)
Cloning of the Murine β5 Integrin Subunit Promoter (1999) (2)
Scientific misconduct: ORI survey is flawed (2002) (2)
Histological manifestations of abnormal parathyroid hormone metabolism in renal osteodystrophy. (1988) (1)
Effect of lithium on parathyroid hormone-induced calcium release from bone rudiments (1979) (1)
Improved microradiographic contrast for bone stain-historadiography. (1976) (1)
The Stimulation of Bone Resorption by Human Breast Cancer Cell Lines (1985) (1)
An improved method for the retrieval of cultured macrophages. (1982) (1)
Recent advances toward understanding osteoclast physiology : Osteopetrosis (1993) (1)
[Continuous and intermittent mechanical forces in orthodontics]. (1990) (1)
Fat implantation in lipodystrophic mice restores susceptibility to joint injury and osteoarthritis independent of body weight (2021) (1)
A Case of Osteomalacia: The Pivotal role of the Non-Decalcified Bone Biopsy (1988) (1)
Hematopoietic vs embryonic sources for stem cell research. (2008) (1)
Tumor Necrosis Factor a Regulates a v b 5 Integrin Expression by Osteoclast Precursors in Vitro and in Vivo* (1999) (1)
Histometric evaluation of nondecalcified bone biopsy specimens in primary hyperparathyroidism. (1975) (1)
Bone loss in chronic alcoholism (CA) (1974) (1)
Genetic variation in the serotonin transporter and serotonin 1B receptor predicts reduced bone formation during serotonin-reuptake inhibitor treatment in older adults (2013) (0)
Pulmonary osteoclast-like cells in silica induced pulmonary fibrosis (2023) (0)
Osteoclasts and Arthritis. (2009) (0)
ThPOK Inhibits Osteoclast Formation Via NFATc1 Transcription and Function (2021) (0)
P21. Species differences in the antigenic phenotype of osteoclasts and mononuclear phagocytes (1992) (0)
Osteosclerosis, osteomalacia, and bone marrow aplasia: A combined late complication of thorotrast administration (2004) (0)
13 – Osteoporosis and the Bone Biopsy (2000) (0)
Development of a Pure Small Molecule αVβ3 Antagonist (2017) (0)
Lithium (LI) inhibition of bone formation (1977) (0)
Remembering Dr Arnold J Kahn: June 18, 1936–June 16, 2021 (2022) (0)
DAP12 Regulates the Osteoclast Cytoskeleton (2013) (0)
Fat-Produced Adipsin Regulates Inflammatory Arthritis Graphical Abstract Highlights (2019) (0)
arthritis model potential of hematopoietic stem cells in a mouse chronic inflammatory Defects in osteoblast function but no changes in long-term repopulating (2013) (0)
Effect of cortisol on macrophage-mediated bone resportion (1979) (0)
Streptozotocin and bone resorption in vitro (1980) (0)
Action of endotoxins on macrophage-mediated bone resorption (1979) (0)
Inhibition of parathyroid hormone-induced fetal rat bone resorption in vitro by nerve growth factor (1978) (0)
Estrogen Enhances CY,& lntegrin Expression by Avian Osteoclast Precursors via Stabilization of p3 lntegrin mRNA (2001) (0)
Conditioned medium from osteoblast-like cells mediate parathyroid hormone induced bone resorption (1987) (0)
Endotoxin suppression of macrophage-mediated bone resorption (1979) (0)
Interleukin-4 transgenic mice: A novel animal model for osteoporosis (1992) (0)
Dr. Louis V. Avioli, 1931–1999 (2000) (0)
Session III: Regulation of bone remodeling (1993) (0)
Human lymphocytes respond to calcitonin (1982) (0)
25-Hydroxyvitamin D3 metabolism in a human leukemia cell line (1986) (0)
Molecular cloning of mouse homologues of Rab3 isoforms in osteoclasts (2000) (0)
Link between IV drug abuse, diffuse osteosclerosis (1992) (0)
Insights into pulmonary phosphate homeostasis and osteoclastogenesis emerge from the study of pulmonary alveolar microlithiasis (2023) (0)
437 SERUM 25-HYDROXY-VITAMIN D (25-OHD) CONCENTRATIONS AND BONE HISTOLOGY IN SUDDEN INFANT DEATH SYNDROME (SIDS) (1978) (0)
Bone metabolism in the alcohol-treated rats (1979) (0)
Osteoclastic Bone Resorption Trafficking Pathway That Is Required for Rab3D Regulates a Novel Vesicular (2014) (0)
Effects of glucocorticoid on macrophage-mediated bone resorption (1982) (0)
Correction: TREM2 and β-catenin regulate bone homeostasis by controlling the rate of osteoclastogenesis (2012) (0)
The Pathology of the Uremic Bone Lesion (1985) (0)
biomedical research Of mice and models: improved animal models for (2015) (0)
Ultrastructure of the rat epiphyseal growth plate following chronic ethanol ingestion (2006) (0)
Alterations in D-Type Cyclins and p27 Osteoclast Precursors via Akt-Dependent SHIP1 Negatively Regulates Proliferation of (2006) (0)
Acquired alterations in bone metabolism during ethanol ingestion (1980) (0)
Effects of glucocorticoids on osteolysis (1982) (0)
Novel insights into pulmonary phosphate homeostasis and osteoclastogenesis emerge from the study of pulmonary alveolar microlithiasis (2021) (0)
Ultrastructural effects of alcohol on the rat skeleton (1980) (0)
370 The non-decalcified bone biopsy in the diagnosis of mastocytosis (1988) (0)
Tumor necrosis factor is necessary for polymethylmethacrylate induced osteolysis in vivo (1998) (0)
Induced Osteoclastogenesis In Vivo α Precursors Differentially Contribute to TNF-Marrow Stromal Cells and Osteoclast (2004) (0)
Soluble RANKL and Risk of Nontraumatic Fracture—Reply (2004) (0)
MALIGNANT OSTEOPETROSIS(OP): OBSERVATIONS ON THE DISEASE SPECTRUM (1984) (0)
Osteoclastogenesis Homeostasis by Controlling the Rate of-Catenin Regulate Bone β TREM 2 and (2012) (0)
Saccharides Mediate the Attachment of Rat (2005) (0)
Gregory Robert Mundy 1942—2010 (2010) (0)
The outlook for biomedical research under the Barack Obama administration (2009) (0)
X-linked hypophosphataemia in adults — Clinical, histological, biochemical and radiological findings (1990) (0)
Mechanisms of Breast Cancer-Induced Osteolysis. (1995) (0)
Abnormalities of Circulating 25-OH Vitamin D after Jejunal-Ileal Bypass for Obesity (2020) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Steven L. Teitelbaum?

Steven L. Teitelbaum is affiliated with the following schools: